Edited by Neil Lunt, Daniel Horsfall and Johanna Hanefeld
Since 1978, five million babies have been born via IVF and its related technologies. However, political and cultural differences between nations and the unequal global spread of Assistive Reproductive Technologies (ARTs) means that the access that individuals have to medicalised solutions to childlessness varies internationally. In response to this variability, cross-border reproductive travel appears to have burgeoned in recent years, though accurate assessment of its extent remains a challenge. This chapter provides a brief overview of the current knowledge on cross-border fertility travel before presenting empirical findings from a qualitative UK study about the experiences of British residents who travel abroad to seek access to ARTs. The ‘Transrep’ study sought to address some of these gaps and this chapter summarises key findings from the study regarding the profile of UK fertility travellers, their motivations, destinations and experiences. These data demonstrate that in a country like the UK, where there is largely liberal and inclusive regulation surrounding access to fertility treatment, the reasons for and direction of patient travel are complex and diverse. Cross-border reproductive travel, a phenomenon at the intersection of kinship, science, politics and commerce, presents a very particular set of ethical and legal dilemmas.
You are not authenticated to view the full text of this chapter or article.
Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.
Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.
Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.